{
    "medicine_id": "2722c70deb81a9f515d3356c2131c3d669510654",
    "platform_id": "DB11571",
    "metadata": {
        "name": "Artiss 70 mg mL Solution",
        "composition": "70 mg mL Human thrombin",
        "clinical_particulars": {
            "therapeutic_indications": "Human thrombin is indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules are accessible and control of bleeding by standard surgical techniques such as suture ligature or cautery is ineffective or impractical FDA Label",
            "contraindications": {
                "disease": "No cases of overdose have been reported at this time FDA Label The LD50 value for the mouse model is calculated to be approximately 3 gm kg MSDS",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Clinical pharmacodynamic studies with human thrombin have not been performed at this time FDA Label Regardless commercial human thrombin products are expected to demonstrate activity that is identical to thrombin found endogenously in the body In the natural blood coagulation pathway of the human body thrombin functions as a coagulation factor that converts clotting factor XI to XIa factor VIII to VIIIa V to Va fibrinogen to fibrin and XIII to XIIIa A32408 Specifically clotting factor XIIIa is a transglutaminase that catalyzes the formation of covalent bonds between the lysine and glutamine residues found in fibrin These covalent bonds assist in increasing the stability of the fibrin clot A32408 Additionally thrombin also promotes the activation and aggregation of platelets by way of activating protease activated receptors on the cell membranes of platelets A32408",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}